Allscripts (MDRX) Introduces New Revenue Management Solution
Tweet Send to a FriendGet Alerts MDRX Hot Sheet
Trade MDRX Now!
Allscripts (Nasdaq: MDRX) Sunrise Financial Manager (SFM), a solution that enables hospitals and health systems to manage revenue in an integrated way across the enterprise, is now available. The latest in a long line of revenue cycle solutions from Allscripts, SFM breaks new ground with its Visual Workflow capabilities, allowing users to configure the financial process to meet the organization's needs and to address constantly changing regulations and payment models in the new world of accountable care.
Sunrise Financial Manager is built on the Sunrise Enterprise 6.0 platform. Allscripts Sunrise Clinical Manager (SCM), Sunrise Financial Manager, Sunrise Enterprise Registration and Sunrise Enterprise Scheduling all run the same platform using one database. This provides Allscripts clients with a modern, integrated clinical and financial platform, designed for use with the new value based care payment models.
Jefferson Regional Medical Center has signed on as an early adopter of SFM. Jefferson is a long-standing user of Sunrise Clinical Manager and Sunrise Enterprise Registration.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sunrise Financial Manager is built on the Sunrise Enterprise 6.0 platform. Allscripts Sunrise Clinical Manager (SCM), Sunrise Financial Manager, Sunrise Enterprise Registration and Sunrise Enterprise Scheduling all run the same platform using one database. This provides Allscripts clients with a modern, integrated clinical and financial platform, designed for use with the new value based care payment models.
Jefferson Regional Medical Center has signed on as an early adopter of SFM. Jefferson is a long-standing user of Sunrise Clinical Manager and Sunrise Enterprise Registration.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Senate Takes Aim at Apple (AAPL); Says Irish Unit Earned $22B, Paid $10M in Taxes
- Regeneron (REGN) and Genentech Strike Deal on Worldwide EYLEA Sales
- Pfizer (PFE) Discontinues Phase 3 Study of Inotuzumab Ozogamicin
Create E-mail Alert Related Categories
Corporate NewsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

